BioAge Labs (BIOA) Non Operating Income (2023 - 2026)

BioAge Labs has disclosed Non Operating Income across 4 years of filings, most recently posting $3.2 million for Q2 2026.

• In Q2 2026, Non Operating Income rose 0.87% year-over-year to $3.2 million; the TTM figure through Jun 2026 stood at $11.8 million (down 4.02% YoY), while the FY2025 annual figure was $12.2 million, up 71.84% from the prior year.
• Non Operating Income came in at $3.2 million for Q2 2026 at BioAge Labs, up from $3.1 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $4.2 million in Q4 2024 to a low of -$7.4 million in Q4 2023.
• Average Non Operating Income over 4 years is $1.1 million, with a median of $2.7 million recorded in 2025.
• The largest YoY upside for Non Operating Income was 2065.36% in 2025 against a maximum downside of 41.41% in 2025.
• Over 4 years, Non Operating Income stood at -$7.4 million in 2023, then jumped by 157.5% to $4.2 million in 2024, then slumped by 41.41% to $2.5 million in 2025, then soared by 30.48% to $3.2 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $3.2 million in Q2 2026, $3.1 million in Q1 2026, and $2.5 million in Q4 2025.